ENDOLIGN - composite material for superior structural implants

At ComPaMED 2007, Invibio presented its ENDOLIGN composite material that is composed of continuous carbon fibers in a PEEK-OPTIMA polymer matrix. Endolign combines the strengths of metal with the benefits of a polymer for the creation of advanced structural implants.

Endolign is an excellent material for structural uses and the replacement of metals in high sustained or cyclic load applications requiring blood, bone or tissue contact of more than 30 days. The composite is available as pre-impregnated tape that can be compression-molded, filament-wound or pultruded into plaques of profiles or as rods that can be heat-formed or transformed through Composite Flow Molding into final parts. Several Endolign composite-based implantable devices already received CE and FDA approvals.
 
The composite material offers a unique combination of features and benefits:
 
Exceptional mechanicals and tailorability
Its excellent tensile strength, stiffness and fatigue behaviour allows the replacement of metal in structural implants, such as cobalt chromium alloys, titanium alloys and stainless steal.
 
Biocompatibility
Endolign ensures a safe, long-term implantation. Biocompatibility tests showed no evidence of cytotoxicity, systemic toxicity, irritation or macroscopic reaction response.
 
Image Compatibility
It is MRI, CT and X-ray compatible, thus allowing a clear visualization of the healing site.
 
 
For more information please visit the manufacturers website http://www.invibio.com

16.11.2007

More on the subject:

Related articles

Photo

News • Signs of life

BCI could help comatose patients communicate

A new study opens the door to noninvasive brain-computer interfaces that could allow seemingly comatose patients in the ICU with hidden consciousness to communicate with doctors and family members.

Photo

Sponsored • Connecting Precision Medicine with Smart Healthcare

Taipei Brings Six Biomedical Innovations to MEDICA 2026

Six Taipei-based biomedical companies will showcase innovations in precision medicine and smart healthcare at MEDICA 2026 (November 16–19, Düsseldorf).

Photo

News • Medical technology

Hernia care: CE mark for non-penetrating mesh fixation

MedTech company Tissium has received CE marking for Eclipsium, a device for non-penetrating mesh fixation in minimally invasive ventral hernia repair. European launch is expected in 2027.

Subscribe to Newsletter